Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.245 USD -0.64% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Neogenomics Inc
Total Liabilities & Equity Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Total Liabilities & Equity
$1.6B
CAGR 3-Years
-5%
CAGR 5-Years
18%
CAGR 10-Years
35%
Thermo Fisher Scientific Inc
NYSE:TMO
Total Liabilities & Equity
$100.4B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
9%
Danaher Corp
NYSE:DHR
Total Liabilities & Equity
$80.6B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
9%
Mettler-Toledo International Inc
NYSE:MTD
Total Liabilities & Equity
$3.2B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Total Liabilities & Equity
$11B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
1%
IQVIA Holdings Inc
NYSE:IQV
Total Liabilities & Equity
$27.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
24%

See Also

What is Neogenomics Inc's Total Liabilities & Equity?
Total Liabilities & Equity
1.6B USD

Based on the financial report for Sep 30, 2024, Neogenomics Inc's Total Liabilities & Equity amounts to 1.6B USD.

What is Neogenomics Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
35%

Over the last year, the Total Liabilities & Equity growth was -2%. The average annual Total Liabilities & Equity growth rates for Neogenomics Inc have been -5% over the past three years , 18% over the past five years , and 35% over the past ten years .

Back to Top